PRIN 2022

Settore ERC Titolo Progetto Responsabile scientifico
LS1 20223RXEEC - Neuroglobin high levels: an inducible pathway to prevent the mitochondrial dysfunctionality accompanying neurodegenerative diseases Roberta Misasi
LS2 2022KCP7YP - Plaiority - Nano/microplastics effects on human health: transcriptional profiles, molecular pathways and inflammatory response associated with cell biology and microbiota dysfunction Simona Ceccarelli 
LS2 20222MTTNX - Deciphering the genetic background of cutaneous melanoma: inquiring into gene-specific oncophenotypes and non-invasive biomarkers of prognosis and therapy response Paola Grammatico 
LS2 2022EHN49M - CHEMOTHERAPY EXPOSURE OF TESTICULAR CANCER SURVIVORS: STUDY OF GENETIC AND EPIGENETIC ALTERATIONS IN SPERMATOZOA Donatella Paoli
LS2 202273HF83 - STUDY OF THE INTERPLAY AMONG GUT MICROBIOTA METABOLITES, VITAMIN D, AND SIRTUINS IN CHRONIC INFLAMMATORY PAIN: NEW DIAGNOSTIC AND THERAPEUTIC PERSPECTIVES Marco Tafani 
LS2 2022RY8549 - Virus associated cancers: Discerning the potential of RNA based nanoimmunotherapeutics in 3D microfluidic biomimetic mdodels Pankaj Trivedi 
LS3 2022XMHSYP - Novel approaches for the characterization and modulation of the oncogenic Sonic Hedgehog pathway in colorectal cancer. Identification of new potential prognostic markers and therapeutic targets. Enrico De Smaele
LS3 2022XL4TE9 - GECO: Golgi-ER Cross-talk and Organisation in health and disease Maurizio Sorice 
LS3 2022APEBMY - Dynamics of ion channel-based macromolecular complexes in triggering mechanotransduction through lipid rafts: towards understanding mechanisms underlying cell invasiveness in pancreatic cancer (MECHIONRAFT) Tina Garofalo
LS4 2022AWB8T4 - The endocrine, vascular and sexual crosstalk in people living with HIV (PLWH): exploratory trial on the role of phosphodiesterase 5 inhibitors Daniele Gianfrilli 
LS4 202279JKW5 - Deregulation of chromatin-associated proteins and its consequences on obesity-related inflammation, systemic insulin resistance and male gonadal dysfunction Carla Lubrano 
LS4 2022NS7PRM - Characterization of overweight/obesity and its relevance in people with autoimmune diabetes Ernesto Maddaloni 
LS4 20223WSTY4 - New metabolic players in browning of adipocytes, thermogenic functions and inflammation. Mary Anna Venneri 
LS4 2022K5RYF5 - Dissecting naïve PD-1+ T-cells phenotype to generate new biological insights of immunotherapy response in advanced NSCLC Ilaria Grazia Zizzari 
LS7 2022MSE59K - Dissecting Androgen and Estrogen Receptor functions in skeletal muscle: in vitro and in vivo models (D.A.Re.) Zein Mersini Besharat
LS7 202229ET3S - Clinical implementation of ESPEN-EASO criteria for diagnosis and staging of sarcopenic obesity Lorenzo Maria Donini
LS7 2022FRSS2H - Theratyping of Cystic Fibrosis Marco Lucarelli
LS7 2022TXHFSA - Novel mediators, predictive biomarkers and therapeutic targets for breast cancer metastatic disease Laura Masuelli
LS7 2022M5LBKP - APtameR based thEragnostiC strategy to impair the crosstalk between glIoma Stem cElls and their niche (PRECISE) Aurelia Rughetti

© Università degli Studi di Roma "La Sapienza" - Piazzale Aldo Moro 5, 00185 Roma